David Risinger
Stock Analyst at Leerink Partners
(4.98)
# 60
Out of 5,014 analysts
1039
Total ratings
65%
Success rate
32.8%
Average return
Main Sectors:
Stocks Rated by David Risinger
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANAB AnaptysBio | Reiterated: Buy | $81 | $50.26 | +61.16% | 35 | Sep 23, 2026 | |
| ENTX Entera Bio | Initiated Coverage: Buy | $9 | $2.91 | +209.28% | 1 | Sep 18, 2026 | |
| LLY Eli Lilly and Company | Reiterated: Buy | n/a | $1,157.08 | - | 121 | Sep 16, 2026 | |
| SCTX Scribe Therapeutics | Initiated Coverage: Buy | $37 | $18.41 | +101.03% | 1 | Aug 18, 2026 | |
| REGN Regeneron Pharmaceuticals | Reiterated: Hold | $641 → $824 | $758.27 | +8.67% | 59 | Aug 17, 2026 | |
| TENX Tenax Therapeutics | Reiterated: Buy | $4 | $1.89 | +111.64% | 10 | Aug 11, 2026 | |
| HALO Halozyme Therapeutics | Upgraded: Buy | $110 | $110.40 | -0.36% | 38 | Aug 7, 2026 | |
| JNJ Johnson & Johnson | Reiterated: Buy | $265 → $276 | $264.74 | +4.25% | 54 | Jul 17, 2026 | |
| ORKA Oruka Therapeutics | Reiterated: Buy | n/a | $83.29 | - | 15 | Jun 2, 2026 | |
| IMA ImageneBio | Reiterated: Buy | $30 → $24 | $4.58 | +424.02% | 2 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $46 | $35.44 | +29.80% | 1 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $261.59 | - | 72 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $421.51 | - | 42 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $62.40 | -3.85% | 71 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $525 | $522.81 | +0.42% | 44 | Dec 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $72.64 | - | 58 | Dec 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $32 | $36.57 | -12.50% | 47 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $26 | $28.52 | -8.84% | 90 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $56.90 | n/a | 27 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $41.23 | n/a | 1 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $23.29 | n/a | 13 | Sep 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $49.98 | n/a | 5 | Aug 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 → $44 | $31.27 | n/a | 24 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $27 → $23 | $192.57 | n/a | 2 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $47.29 | n/a | 1 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.97 | n/a | 1 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $11.02 | n/a | 1 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $91 | $149.05 | n/a | 12 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $10.15 | n/a | 1 | Mar 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $33 | $13.70 | n/a | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $176 | $231.52 | n/a | 12 | May 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $20 → $22 | $35.77 | n/a | 15 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 | $145.31 | n/a | 34 | Apr 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $18 → $16 | $17.72 | n/a | 24 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $53 → $45 | $14.76 | n/a | 19 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $49.52 | $8.29 | n/a | 32 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 → $22 | $40.52 | n/a | 19 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $167 → $41 | $22.39 | n/a | 8 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $167 → $174 | $69.83 | n/a | 16 | Nov 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $51 | $58.36 | n/a | 1 | Jul 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $18 → $3 | $20.14 | n/a | 4 | Apr 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $300.25 | n/a | 2 | Nov 16, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $137.30 | n/a | 3 | Sep 21, 2012 |
AnaptysBio
Sep 23, 2026
Reiterated: Buy
Price Target: $81
Current: $50.26
Upside: +61.16%
Entera Bio
Sep 18, 2026
Initiated Coverage: Buy
Price Target: $9
Current: $2.91
Upside: +209.28%
Eli Lilly and Company
Sep 16, 2026
Reiterated: Buy
Price Target: n/a
Current: $1,157.08
Upside: -
Scribe Therapeutics
Aug 18, 2026
Initiated Coverage: Buy
Price Target: $37
Current: $18.41
Upside: +101.03%
Regeneron Pharmaceuticals
Aug 17, 2026
Reiterated: Hold
Price Target: $641 → $824
Current: $758.27
Upside: +8.67%
Tenax Therapeutics
Aug 11, 2026
Reiterated: Buy
Price Target: $4
Current: $1.89
Upside: +111.64%
Halozyme Therapeutics
Aug 7, 2026
Upgraded: Buy
Price Target: $110
Current: $110.40
Upside: -0.36%
Johnson & Johnson
Jul 17, 2026
Reiterated: Buy
Price Target: $265 → $276
Current: $264.74
Upside: +4.25%
Oruka Therapeutics
Jun 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $83.29
Upside: -
ImageneBio
May 8, 2026
Reiterated: Buy
Price Target: $30 → $24
Current: $4.58
Upside: +424.02%
Apr 24, 2026
Initiated Coverage: Buy
Price Target: $46
Current: $35.44
Upside: +29.80%
Jan 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $261.59
Upside: -
Jan 13, 2026
Reiterated: Hold
Price Target: n/a
Current: $421.51
Upside: -
Jan 13, 2026
Reiterated: Buy
Price Target: $60
Current: $62.40
Upside: -3.85%
Dec 29, 2025
Reiterated: Buy
Price Target: $525
Current: $522.81
Upside: +0.42%
Dec 24, 2025
Reiterated: Buy
Price Target: n/a
Current: $72.64
Upside: -
Dec 15, 2025
Reiterated: Buy
Price Target: $22 → $32
Current: $36.57
Upside: -12.50%
Dec 9, 2025
Reiterated: Hold
Price Target: $26
Current: $28.52
Upside: -8.84%
Oct 1, 2025
Reiterated: Buy
Price Target: n/a
Current: $56.90
Upside: n/a
Sep 4, 2025
Reiterated: Buy
Price Target: n/a
Current: $41.23
Upside: n/a
Sep 1, 2025
Reiterated: Buy
Price Target: n/a
Current: $23.29
Upside: n/a
Aug 17, 2025
Reiterated: Buy
Price Target: n/a
Current: $49.98
Upside: n/a
Aug 7, 2025
Reiterated: Buy
Price Target: $60 → $44
Current: $31.27
Upside: n/a
Apr 16, 2025
Reiterated: Sell
Price Target: $27 → $23
Current: $192.57
Upside: n/a
Feb 24, 2025
Initiated Coverage: Buy
Price Target: $28
Current: $47.29
Upside: n/a
Jan 17, 2025
Reiterated: Hold
Price Target: n/a
Current: $3.97
Upside: n/a
May 1, 2024
Reiterated: Buy
Price Target: n/a
Current: $11.02
Upside: n/a
Apr 28, 2023
Reiterated: Hold
Price Target: $91
Current: $149.05
Upside: n/a
Mar 14, 2023
Reiterated: Buy
Price Target: n/a
Current: $10.15
Upside: n/a
Jun 11, 2021
Initiated Coverage: Hold
Price Target: $33
Current: $13.70
Upside: n/a
May 21, 2021
Reiterated: Hold
Price Target: $176
Current: $231.52
Upside: n/a
May 13, 2021
Reiterated: Sell
Price Target: $20 → $22
Current: $35.77
Upside: n/a
Apr 1, 2021
Reiterated: Buy
Price Target: $90
Current: $145.31
Upside: n/a
Mar 10, 2021
Reiterated: Hold
Price Target: $18 → $16
Current: $17.72
Upside: n/a
Mar 5, 2021
Reiterated: Hold
Price Target: $53 → $45
Current: $14.76
Upside: n/a
Feb 26, 2021
Reiterated: Hold
Price Target: $49.52
Current: $8.29
Upside: n/a
Dec 21, 2020
Reiterated: Hold
Price Target: $16 → $22
Current: $40.52
Upside: n/a
Nov 23, 2020
Reiterated: Buy
Price Target: $167 → $41
Current: $22.39
Upside: n/a
Nov 13, 2020
Reiterated: Hold
Price Target: $167 → $174
Current: $69.83
Upside: n/a
Jul 13, 2020
Initiated Coverage: Hold
Price Target: $51
Current: $58.36
Upside: n/a
Apr 2, 2020
Reiterated: Hold
Price Target: $18 → $3
Current: $20.14
Upside: n/a
Nov 16, 2015
Upgraded: Hold
Price Target: n/a
Current: $300.25
Upside: n/a
Sep 21, 2012
Reiterated: Buy
Price Target: $36
Current: $137.30
Upside: n/a